Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level

NCT01396070 is registered in ClinicalTrials.gov with Youn Kim as lead sponsor.

NCT NCT01396070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01396070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level
Lead sponsor
Youn Kim
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2011
Completion date
May 31, 2016
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous lymphoma, cutaneous t-cell lymphoma (ctcl), mycosis fungoides, non-hodgkin lymphoma (nhl), sezary syndrome